Hospitals were never thrilled with the Hospital Price Transparency rule, and a recent independent review shows they have done little to comply with the regulation aimed at helping consumers choose...
In the modern-day take on A Tale of Two Cities, the threat of COVID-19 has become a matter of where you live, putting clearly in harm's way those without the power to be vaccinated or avoid the...
Happy Tuesday! Folks on either coast of the United States are facing either record high temperatures or levels of rainfall. As is the case most times, meteorologists are the only ones satisfied.
FDA...
While the pandemic shone a bright light on mental health, many Americans faced struggles accessing counseling services due to cost and other barriers. As Delta variant becomes the dominant strain of...
Welcome back to work after a long (and for many in the Northeast rainy) weekend. Direct-to-consumer marketing appears to be paying off for pharma companies as far as Medicare drug spending is...
United States officials have paused the distribution of Eli Lilly’s COVID-19 antibody therapy after it proves ineffective against variants. New research shows the ground ambulance rides are...
In perhaps a wake-up call to pharmaceutical companies, pharmacy benefit managers, and payers, data from GoodRx shows that its platform has generated $30 billion in savings for consumers to date. In...
Real-world data shows that Gilead’s remdesivir reduces the risk of mortality for COVID-19 patients. Precision medicine is set for advancement at Weill Cornell Medicine with the launch of a...
Good news: A Phase 3 study of Regeneron’s COVID-19 antibody cocktail shows that the therapy is effective in reducing the risk of death for patients suffering from the virus. The bad news:...
The approval by FDA of Biogen’s Alzheimer’s drug Aduhelm has led to the resignation of three committee members, citing disagreement with the department’s decision. The efficacy of the...
It’s been a busy week in healthcare, beginning with FDA’s approval of Biogen’s Alzheimer’s drug, Aduhelm, which continues to draw the ire of industry experts across the...
A heatwave has many across the country seeking shelter for a different reason. Stay cool out there!
FDA APPROVES BIOGEN’S ALZHEIMER’S DRUG AFTER DEBATE
The FDA has officially approved...
Happy Friday after a long short week of work. Many of us in the Northeast will be scrambling to the coast to get some sun following a bleak and dreary Memorial Day Weekend.
Press Ganey Gets OK from...
It’s already Wednesday. With a short week, the roundup will publish today and Friday. Here’s what is making news across healthcare.
Biden Seeks to Boost HHS Budget by 23 Percent
As part...
Happy Tuesday. With the weekend comes Memorial Day and the relaxation of many COVID-19 restrictions.
Google Set to Bring Artificial Intelligence to Dermatology
Google debuted a dermatology tool...
Happy Thursday. A downward trend in COVID-19 cases and deaths is good news as reopening moves forward across the nation.
Patient Engagement Technology a Top CIO Priority in 2021
Patient engagement...
Happy Thursday and hold onto your masks (depending on where you reside).
BIAS HOLDING BACK HEALTHCARE ARTIFICIAL INTELLIGENCE
To ensure the safe and effective use of artificial intelligence in...
Happy Thursday and welcome to a run-down on the latest developments across the healthcare industry.
Kaiser Permanente, Mayo Clinic Partner for Home Health
Kaiser Permanente and the Mayo Clinic are...
Happy Tuesday as warm temps and dry skies seem to be in the forecast for many of us.
JAMA Study Finds 15% Increase in Out-of-Pocket Costs for Branded Drugs
A JAMA study found that for 53.7% of...
Happy Thursday. The weekend is fast approaching and with it the Kentucky Derby.
CMS Proposes Payment Increase to Boost Rural Health
CMS is proposing to increase Medicare hospital inpatient rates by...
